600 participants
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-23
- Start Date:
- 2026-07-31
- Completion:
- 2028-03-31
Conditions
- Metastatic Castration Resistant Prostate Cancer
Interventions
- DRUG
No Results Yet